The discovery and development of RNA-based therapies for treatment of HIV-1 infection
MJ Chen, A Gatignol… - Expert Opinion on Drug …, 2023 - Taylor & Francis
Introduction Long-term control of HIV-1 infection can potentially be achieved using
autologous stem cell transplants with gene-modified cells. Non-coding RNAs represent a …
autologous stem cell transplants with gene-modified cells. Non-coding RNAs represent a …
Modulation of RNA splicing by oligonucleotides: Mechanisms of action and therapeutic implications
Dysregulation of RNA splicing causes many diseases and disorders. Several therapeutic
approaches have been developed to correct aberrant alternative splicing events for the …
approaches have been developed to correct aberrant alternative splicing events for the …
Processing and transcriptome expansion at the mRNA 3′ end in health and disease: finding the right end
A Ogorodnikov, Y Kargapolova… - Pflügers Archiv-European …, 2016 - Springer
The human transcriptome is highly dynamic, with each cell type, tissue, and organ system
expressing an ensemble of transcript isoforms that give rise to considerable diversity. Apart …
expressing an ensemble of transcript isoforms that give rise to considerable diversity. Apart …
Could gene therapy cure HIV?
Abstract The Human Immunodeficiency Virus (HIV)/Acquired Immune Deficiency Syndrome
(AIDS) continues to be a major global public health issue, having claimed almost 33 million …
(AIDS) continues to be a major global public health issue, having claimed almost 33 million …
Development of engineered-U1 snRNA therapies: current status
M Gonçalves, JI Santos, MF Coutinho, L Matos… - International Journal of …, 2023 - mdpi.com
Splicing of pre-mRNA is a crucial regulatory stage in the pathway of gene expression. The
majority of human genes that encode proteins undergo alternative pre-mRNA splicing and …
majority of human genes that encode proteins undergo alternative pre-mRNA splicing and …
Examining the capacity of human U1 snRNA variants to facilitate pre-mRNA splicing
J Wong, R Yellamaty, C Gallante, E Lawrence… - RNA, 2024 - rnajournal.cshlp.org
The human U1 snRNA is encoded by a multigene family consisting of transcribed variants
and defective pseudogenes. Many variant U1 (vU1) snRNAs have been demonstrated to not …
and defective pseudogenes. Many variant U1 (vU1) snRNAs have been demonstrated to not …
[HTML][HTML] A U1i RNA that enhances HIV-1 RNA splicing with an elongated recognition domain is an optimal candidate for combination HIV-1 gene therapy
O Del Corpo, RP Goguen, CMG Malard, A Daher… - … Therapy-Nucleic Acids, 2019 - cell.com
U1 interference (U1i) RNAs can be designed to correct splicing defects and target
pathogenic RNA, such as HIV-1 RNA. In this study, we show that U1i RNAs that enhance …
pathogenic RNA, such as HIV-1 RNA. In this study, we show that U1i RNAs that enhance …
Gene therapy to cure HIV infection
RP Goguen, MJ Chen, ORS Dunkley, A Gatignol… - Virologie, 2023 - shs.cairn.info
Gene therapy to cure HIV infection | Cairn.info Cairn.info, Matières à réflexion Cairn.info,
Matières à réflexion Aucune suggestion trouvée Compte personnel Adresse email Mon mot de …
Matières à réflexion Aucune suggestion trouvée Compte personnel Adresse email Mon mot de …
Evaluation of the efficacy and toxicity of RNAs targeting HIV-1 production for use in gene or drug therapy
RJ Scarborough, KL Adams… - Journal of …, 2016 - pmc.ncbi.nlm.nih.gov
Small RNA therapies targeting post-integration steps in the HIV-1 replication cycle are
among the top candidates for gene therapy and have the potential to be used as drug …
among the top candidates for gene therapy and have the potential to be used as drug …
Thérapie génique pour guérir l'infection par le VIH
RP Goguen, MJ Chen, ORS Dunkley, A Gatignol… - Virologie, 2023 - shs.cairn.info
À ce jour, la seule intervention qui a pu guérir l'infection par le VIH a été la greffe de moelle
osseuse de donneurs résistants au VIH à des receveurs infectés par le VIH. Cette approche …
osseuse de donneurs résistants au VIH à des receveurs infectés par le VIH. Cette approche …